Neuronetics, Inc. (STIM) — 8-K Filings

8-K Filings (26)

• 8-K Filing — May 5, 2026
• Neuronetics Files 8-K: Operations, Personnel & Financials — Nov 4, 2025 Risk: medium
  Neuronetics, Inc. filed an 8-K on November 4, 2025, reporting on its results of operations and financial condition. The filing also covers the departure of dire
• 8-K Filing — Aug 5, 2025
• Neuronetics, Inc. Reports Board and Executive Changes — Jul 15, 2025 Risk: medium
  On July 15, 2025, Neuronetics, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the departu
• Neuronetics, Inc. Files 8-K on Shareholder Vote Matters — May 28, 2025 Risk: low
  Neuronetics, Inc. filed an 8-K on May 28, 2025, reporting on matters submitted to a vote of security holders as of May 22, 2025. The filing details the company'
• Neuronetics Announces CFO Departure, Appoints Interim CFO, Adds Directors — May 6, 2025 Risk: medium
  On May 6, 2025, Neuronetics, Inc. filed an 8-K report detailing several key events. The company announced the departure of its Chief Financial Officer, Todd L.
• Neuronetics Adds Two Directors to Board — Mar 4, 2025 Risk: low
  Neuronetics, Inc. announced on February 24, 2025, a change in its board of directors. Specifically, the company elected two new directors, Dr. David M. D. Smith
• Neuronetics, Inc. Files 8-K: Material Agreement and Other Events — Feb 10, 2025 Risk: medium
  On February 7, 2025, Neuronetics, Inc. entered into a Material Definitive Agreement. The company also reported other events and filed financial statements and e
• Neuronetics, Inc. Files 8-K for Financial Reporting — Jan 13, 2025 Risk: low
  Neuronetics, Inc. filed an 8-K on January 13, 2025, reporting on its Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Stat
• Neuronetics Files 8-K: Agreements, Acquisitions, Officer Changes — Dec 10, 2024 Risk: medium
  On December 10, 2024, Neuronetics, Inc. filed an 8-K report detailing several significant events. These include the entry into a material definitive agreement,
• 8-K Filing — Nov 12, 2024
• Neuronetics, Inc. Files 8-K: Material Agreement & Exhibits — Nov 1, 2024 Risk: low
  On November 1, 2024, Neuronetics, Inc. filed an 8-K report. The filing primarily concerns the entry into a material definitive agreement and includes financial
• Neuronetics, Inc. Files 8-K — Oct 4, 2024 Risk: low
  Neuronetics, Inc. filed an 8-K on October 4, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain speci
• Neuronetics, Inc. Files 8-K Report — Oct 2, 2024 Risk: low
  On October 2, 2024, Neuronetics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No spec
• Neuronetics, Inc. Files 8-K Report — Aug 15, 2024 Risk: low
  On August 15, 2024, Neuronetics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No spec
• Neuronetics to be Acquired by HealthTronics Affiliate — Aug 14, 2024 Risk: medium
  On August 13, 2024, Neuronetics, Inc. announced a definitive agreement to be acquired by an affiliate of HealthTronics, Inc. The transaction is expected to clos
• Neuronetics Amends Credit Agreement with MidCap Financial Trust — Aug 13, 2024 Risk: low
  On August 11, 2024, Neuronetics, Inc. entered into a Material Definitive Agreement, specifically a Second Amendment to its Credit Agreement with MidCap Financia
• Neuronetics, Inc. Files 8-K Report — Aug 12, 2024 Risk: low
  On August 12, 2024, Neuronetics, Inc. filed an 8-K report detailing its financial results and other material information. The filing includes information on the
• Neuronetics, Inc. Enters and Terminates Agreements — Jul 30, 2024 Risk: medium
  On July 25, 2024, Neuronetics, Inc. entered into a Material Definitive Agreement and also terminated a Material Definitive Agreement. The company also created a
• Neuronetics, Inc. Files 8-K Report — Jun 6, 2024 Risk: low
  On June 6, 2024, Neuronetics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The compan
• Neuronetics Stockholders Vote on Directors and Executive Compensation — Jun 3, 2024 Risk: low
  On May 30, 2024, Neuronetics, Inc. announced the results of its 2024 Annual Meeting of Stockholders. The company's stockholders voted to elect three Class II di
• Neuronetics Appoints New Chief Medical Officer — Mar 28, 2024 Risk: low
  Neuronetics, Inc. announced on March 25, 2024, the appointment of Dr. Christopher R. White as Chief Medical Officer. Dr. White previously served as Chief Medica
• Neuronetics, Inc. Files 8-K Report — Mar 25, 2024 Risk: low
  On March 25, 2024, Neuronetics, Inc. filed an 8-K report detailing an "Other Event." The filing does not contain specific financial figures or significant opera
• Neuronetics Announces CFO Departure, Appoints Interim — Mar 6, 2024 Risk: medium
  Neuronetics, Inc. announced on February 29, 2024, the departure of its Chief Financial Officer, Michael R. Rago, effective March 1, 2024. The company also appoi
• Neuronetics, Inc. Files 8-K for Regulation FD Disclosure — Mar 5, 2024 Risk: low
  On March 5, 2024, Neuronetics, Inc. filed an 8-K report. The filing primarily concerns a Regulation FD Disclosure, indicating a public disclosure of material in
• Neuronetics Files 8-K on Financial Condition, Operations — Jan 8, 2024
  Neuronetics, Inc. filed an 8-K on January 8, 2024, to report on its results of operations and financial condition. This filing, under SEC File Number 001-38546,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX